Wild, D., Kerr, M., Figueiredo, C. and Partridge, H. (2023), Evaluation of integrated diabetes and mental health care for type 1 diabetes and disordered eating (T1DE): the ComPASSION service. Pract Diab, 40: 19-23. https://doi.org/10.1002/pdi.2445

 

Kerr M,  Barron E,  Chadwick P, Evans T, Kong WM, Rayman G, Sutton-Smith M, Todd G, Young B, Jeffcoate WJ, The cost of diabetic foot ulcers and amputations to the National Health Service in England, Diabet Med. 2019  

Diabet. Med. https://doi.org/10.1111/dme.13973

​

Kerr M. Cost of Diabetic Foot Disease in England, in Boulton AJM et al. (eds.) The Foot in Diabetes, Wiley-Blackwell 2020

​

Kerr M, Pears R, Miedzybrodzka Z, Haralambos K, Cather M, Watson M, et al. Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK. European heart journal 2017; 38:1832-1839

​

Kerr M, Matthews B, Medcalf J.D, O’Donoghue D. End-of-life care for people with chronic kidney disease: cause of death, place of death and hospital costs. NDT 2016; doi: 10.1093/ndt/gfw098

​

Kerr M, Bedford M, Matthews B, O'Donoghue D. The economic impact of acute kidney injury in England. NDT 2014;29(7):1362-8

​

Kerr M, Rayman G, Jeffcoate WJ. Cost of diabetic foot disease to the National Health Service in England. Diabet Med. 2014 Dec;31(12):1498-504. Epub 2014 Aug 1

​

Kerr M. Economic Aspects of Footcare in Hinchliffe et al. (eds.) The Diabetic Foot, J. P. Medical Ltd. 2014

 

Kerr M. Costs and Benefits of Antithrombotic Therapy in Atrial Fibrillation in England: An Economic Analysis based on GRASP-AF, NHS Improving Quality 2014

​

Kerr M, Bray B, Medcalf J, O'Donoghue DJ, Matthews B. Estimating the financial cost of chronic kidney disease to the NHS in England. NDT 2012;27 Suppl 3:iii73-80. 2012